|
|
Line 22: |
Line 22: |
|
| |
|
| :"The bottom line is that anyone who claims they have a 80% or higher success rate in helping typical smokers to abstain long-term is kidding themselves or trying to fool you. Same goes for anyone claiming >50%, particularly if there is no pharmacological component to the intervention. This includes varenicline, e-cigs or anything else we currently have. Generally speaking, a 1 year quit rate above 10% is not bad, 20% is very good, and 25% is awesome." | | :"The bottom line is that anyone who claims they have a 80% or higher success rate in helping typical smokers to abstain long-term is kidding themselves or trying to fool you. Same goes for anyone claiming >50%, particularly if there is no pharmacological component to the intervention. This includes varenicline, e-cigs or anything else we currently have. Generally speaking, a 1 year quit rate above 10% is not bad, 20% is very good, and 25% is awesome." |
| | |
| | His brief evaluations is here |
| | [[File:20201228235541 Fw- (Nicotine Policy) Allen Carr s Easyway Partners With the World Health Organisation for U.pdf|frame|center]] |
|
| |
|
| ==Cost of the easyway program== | | ==Cost of the easyway program== |